HYSEQ INC
10-Q, EX-27.0, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: HYSEQ INC, 10-Q, EX-10.5, 2000-08-14
Next: OPTICAL SENSORS INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS TABLE BELOW HOLDS SUMMARY FINANCIAL INFORMATION CONTAINED IN HYSEQ, INC.
INTERIM FINANCIAL REPORT ON FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2000 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          14,657
<SECURITIES>                                     7,732
<RECEIVABLES>                                    1,623
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                24,643
<PP&E>                                          18,216
<DEPRECIATION>                                 (7,216)
<TOTAL-ASSETS>                                  38,217
<CURRENT-LIABILITIES>                           14,173
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        79,267
<OTHER-SE>                                    (61,151)
<TOTAL-LIABILITY-AND-EQUITY>                    38,217
<SALES>                                              0
<TOTAL-REVENUES>                                 3,574
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 8,905
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (201)
<INCOME-PRETAX>                                (5,112)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (5,112)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,112)
<EPS-BASIC>                                     (0.38)
<EPS-DILUTED>                                   (0.38)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission